Benefits related to your heart health are still being studied
While most symptoms improve within 4-8 weeks, knowing when to seek medical attention ensures safe, effective use of this weight management medication
The trial met all primary and key secondary endpoints, demonstrating significant improvements in both weight loss and pain reduction at 68 weeks
PlexusDx provides compounded GLP-1 medications through licensed 503A pharmacies and offers genetic testing for peptide pathway predispositions
For the full Phase 2 statistics including adverse event rates, discontinuation breakdown, and cohort-by-cohort numbers, see the Retatrutide Statistics 2026 data page
Lee DH, Steffes MW, Jacobs DR Jr